Correlation of GSTM1 gene deletion in joint synovial fluid with the recovery of patients undergoing artificial hip replacement

Lin,Xiangbo; Xu,Tao; Wu,Bin; Hu,Bing; Qin,Ming

doi:10.3892/etm.2018.6661

Correlation of GSTM1 gene deletion in joint synovial fluid with the recovery of patients undergoing artificial hip replacement

Authors:
- Xiangbo Lin
- Tao Xu
- Bin Wu
- Bing Hu
- Ming Qin
View Affiliations

Affiliations: Department of Orthopedics, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China, Department of Orthopedics, Juxian People's Hospital, Rizhao, Shandong 276500, P.R. China, Department of Orthopedics, Affiliated Hospital of Jining Medical University, Jining, Shandong 272001, P.R. China, Department of Ultrasound, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China
Published online on: August 28, 2018 https://doi.org/10.3892/etm.2018.6661
Pages: 3821-3826

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study was designed to investigate the correlation between glutathione S‑transferase M1 (GSTM1) gene polymorphism and the recovery of patients undergoing artificial hip replacement. A total of 241 patients including 149 males (61.8%) and 92 females (38.9%) who received artificial hip replacement in People's Hospital of Rizhao between December 2010 and October 2016 were enrolled to serve as the observation group. Patients were divided into two subgroups according to the loss of GSTM1. A total of 80 healthy subjects who udenrwent a physical examination in our hospital at the same period were selected to serve as the control group. The control group included 41 males (51.25%) and 39 females (48.75%). GSTM1 gene genotyping was performed by polymerase chain reaction‑restriction fragment length polymorphism (PCR‑RFLP). All patients were followed up for 12 months. Clinical data were compared between the deletion and non‑deletion groups and the hospitalization time and the length of the use of antibiotics were compared. Deletion rate of GSTM1 gene in the observation group was 67.63%, which was significantly different from that in the healthy control group [odds ratio (OR)=1.51, 95% confidence interval (CI): 1.075‑2.023, P<0.05]. Notably, a significant difference was indicated in the recovery between patients with and without GSTM1 gene deletion after a year discharged from hospital (P<0.05). There was no significant difference according to sex, age, hypertension, smoking history, leukocyte, hemoglobin, platelet and BMI index between patients in deletion and non‑deletion groups (P>0.05). However, there was a significant difference in the number of patients with diabetes between the two groups (P<0.05). Hospitalization time and the length of antibiotics use were significantly longer in deletion group compared with non‑deletion group (P<0.05). Infection rate in the deletion group was significantly higher than that in the non‑deletion group. Results suggested that GSTM1 gene polymorphism may be correlated with recovery of patients undergoing artificial hip replacement, and GSTM1 gene deletion may correlated with poor recovery.

View Figures

View References

1	van der Pas SL, Nelissen RGHH and Fiocco M: Patients with staged bilateral total joint arthroplasty in registries: Immortal time bias and methodological options. J Bone Joint Surg Am. 99:e822017. View Article : Google Scholar : PubMed/NCBI
2	Warth LC, Callaghan JJ, Liu SS, Klaassen AL, Goet DD and Johnston RC: Thirty-five-year results after Charnley total hip arthroplasty in patients less than fifty years old: A concise follow-up of previous reports. J Bone Joint Surg Am. 96:1814–1819. 2014. View Article : Google Scholar : PubMed/NCBI
3	Cadossi M, Mazzotti A, Baldini N, Giannini S and Savarino L: New couplings, old problems: Is there a role for ceramic-on-metal hip arthroplasty? J Biomed Mater Res B Appl Biomater. 104:204–209. 2016. View Article : Google Scholar : PubMed/NCBI
4	Piacentini S, Polimanti R, Porreca F, Martínez-Labarga C, De Stefano GF and Fuciarelli M: GSTT1 and GSTM1 gene polymorphisms in European and African populations. Mol Biol Rep. 38:1225–1230. 2011. View Article : Google Scholar : PubMed/NCBI
5	Zhang X, Lin J, Wu X, Lin Z, Ning B, Kadlubar S and Kadlubar FF: Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer. Int J Mol Epidemiol Genet. 3:228–236. 2012.PubMed/NCBI
6	Wang J, Zou L, Huang S, Lu F, Lang X, Han L, Song Z and Xu Z: Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease. Mutagenesis. 25:365–369. 2010. View Article : Google Scholar : PubMed/NCBI
7	Tang ZH, Zhang C, Cheng P, Sun HM, Jin Y, Chen YJ and Huang F: Glutathione-S-transferase polymorphisms (GSTM1, GSTT1 and GSTP1) and acute leukemia risk in Asians: A meta-analysis. Asian Pac J Cancer Prev. 15:2075–2081. 2014. View Article : Google Scholar : PubMed/NCBI
8	Singh S: Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemother Pharmacol. 75:1–15. 2015. View Article : Google Scholar : PubMed/NCBI
9	Tamaki Y, Arai T, Sugimura H, Sasaki T, Honda M, Muroi Y, Matsubara Y, Kanno S, Ishikawa M, Hirasawa N and Hiratsuka M: Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug Metab Pharmacokinet. 26:516–522. 2011. View Article : Google Scholar : PubMed/NCBI
10	Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, Zhang D and Zhou W: Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis. J Hepatol. 53:508–518. 2010. View Article : Google Scholar : PubMed/NCBI
11	García-González MA, Quintero E, Bujanda L, Nicolás D, Benito R, Strunk M, Santolaria S, Sopeña F, Badía M, Hijona E, et al: Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis. 27:771–777. 2012. View Article : Google Scholar : PubMed/NCBI
12	Wei Y, Zhou T, Lin H, Sun M, Wang D, Li H and Li B: Significant associations between GSTM1/GSTT1 polymorphisms and nasopharyngeal cancer risk. Tumor Biol. 34:887–894. 2013. View Article : Google Scholar
13	Raza S, Abbas S, Ahmad A, Ahmed F, Zaidi Zh and Mahdi F: Association of glutathione-S-transferase (GSTM1 and GSTT1) and FTO gene polymorphisms with type 2 diabetes mellitus cases in Northern India. Balkan J Med Genet. 17:47–54. 2014. View Article : Google Scholar : PubMed/NCBI
14	Van Ness PH, Peduzzi PN and Quagliarello VJ: Efficacy and effectiveness as aspects of cluster randomized trials with nursing home residents: Methodological insights from a pneumonia prevention trial. Contemp Clin Trials. 33:1124–1131. 2012. View Article : Google Scholar : PubMed/NCBI
15	Kalairajah Y, Azurza K, Hulme C, Molloy S and Drabu KJ: Health outcome measures in the evaluation of total hip arthroplasties-a comparison between the Harris hip score and the Oxford hip score. J Arthroplasty. 20:1037–1041. 2005. View Article : Google Scholar : PubMed/NCBI
16	Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, Cameron PA, Graves SE and Cicuttini FM: Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: A systematic review. J Arthroplasty. 25:1216–1222 e1-e3. 2010. View Article : Google Scholar : PubMed/NCBI
17	Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP and Berry DJ: Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 94:794–800. 2012. View Article : Google Scholar : PubMed/NCBI
18	Schrama JC, Espehaug B, Hallan G, Engesaeter LB, Furnes O, Havelin LI and Fevang BT: Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: A prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken). 62:473–479. 2010. View Article : Google Scholar : PubMed/NCBI
19	Hashemi M, Eskandari-Nasab E, Fazaeli A, Taheri M, Rezaei H, Mashhadi M, Arbabi F, Kaykhaei MA, Jahantigh M and Bahari G: Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 6:797–803. 2012. View Article : Google Scholar : PubMed/NCBI
20	Wang IJ, Guo YL, Lin TJ, Chen PC and Wu YN: GSTM1, GSTP1, prenatal smoke exposure, and atopic dermatitis. Ann Allergy Asthma Immunol. 105:124–129. 2010. View Article : Google Scholar : PubMed/NCBI
21	Abdel Rahman HA, Khorshied MM, Elazzamy HH and Khorshid OM: The link between genetic polymorphism of glutathione-S-transferases, GSTM1, and GSTT1 and diffuse large B-cell lymphoma in Egypt. J Cancer Res Clin Oncol. 138:1363–1368. 2012. View Article : Google Scholar : PubMed/NCBI
22	Borst L, Buchard A, Rosthøj S, Wesolowska A, Wehner PS, Wesenberg F, Dalhoff K and Schmiegelow K: Gene dose effects of GSTM1, GSTT1 and GSTP1 polymorphisms on outcome in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 34:38–42. 2012. View Article : Google Scholar : PubMed/NCBI
23	Yang LM, Li XH and Bao CF: Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors. Asian Pac J Cancer Prev. 13:5883–5886. 2012. View Article : Google Scholar : PubMed/NCBI
24	Yao ZG, Yong E and Wang HY: The interacted effects between glutathione S-transferase gene polymorphism and smoking in lung cancer. Chinese J Med Guide. 14:185–186. 882012.(In Chinese).